Related Experiment Video
Updated: Jan 28, 2026

Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
Published on: February 23, 2024
Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease
1Department of Neurology, Mayo Clinic, Rochester, MN 55905.
Abstract:
The mechanisms of myelin injury and repair were studied in acute multiple sclerosis lesions and in a murine model of demyelination induced by a virus. Injury to oligodendrocytes resulting in degeneration of inner glial loops and inner myelin lamellae (dying-back oligodendrogliopathy) was observed by electron microscopy in brain biopsies of acute demyelinating lesions. Attempts at central nervous system remyelination as manifested by thinly myelinated axons and proliferation of oligodendrocytes were observed at the edge of many acute plaques. To develop therapeutic strategies to inhibit demyelination or promote remyelination, mice infected intracranially with Theiler's virus (a picornavirus) were studied. Experimental manipulation of Theiler's virus-infected mice by treatment during chronic demyelinating disease with immunoglobulins directed at normal spinal cord antigens or with monoclonal antibodies which deplete CD4 or CD8-positive T cells resulted in augmentation of new myelin synthesis. These observations suggest that disturbances in the myelinating function of oligodendrocytes, events not accompanied by death of these cells, may be among the earliest pathological events in multiple sclerosis. Experiments using the Theiler's virus model of demyelination indicate that manipulation of the immune response has the potential to promote central nervous system remyelination and functional recovery in multiple sclerosis.
Insights
Early myelin injury in multiple sclerosis may involve oligodendrocyte dysfunction, not cell death. Immune system manipulation in a mouse model promoted myelin repair, suggesting therapeutic potential for central nervous system remyelination.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Multiple sclerosis (MS) is a demyelinating disease characterized by myelin sheath damage in the central nervous system (CNS).
- Understanding the early events of myelin injury and the potential for repair is crucial for developing effective MS therapies.
Purpose of the Study:
- To investigate the mechanisms of myelin injury and repair in acute MS lesions and a viral-induced demyelination model.
- To explore therapeutic strategies for inhibiting demyelination and promoting remyelination in the CNS.
Main Methods:
- Electron microscopy analysis of acute demyelinating lesions in human brain biopsies.
- Intracranial infection of mice with Theiler's virus to model chronic demyelinating disease.
- Experimental manipulation using immunoglobulins and monoclonal antibodies targeting T cells in infected mice.
Main Results:
- Observed oligodendrocyte injury (dying-back oligodendrogliopathy) without cell death in acute MS lesions.
- Evidence of attempted CNS remyelination at the edges of acute plaques.
- Treatment of virus-infected mice with specific immunotherapies augmented new myelin synthesis.
Conclusions:
- Oligodendrocyte dysfunction, not necessarily cell death, may be an early pathological event in MS.
- Modulating the immune response holds promise for promoting CNS remyelination and functional recovery in MS.
Related Concept Videos
What is a Nervous System?
The Parasympathetic Nervous System
The Sympathetic Nervous System
The Central Dogma
Viral Recombination
Nervous System

